carbamazepine has been researched along with Mucopolysaccharidosis VI in 1 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Mucopolysaccharidosis VI: Mucopolysaccharidosis with excessive CHONDROITIN SULFATE B in urine, characterized by dwarfism and deafness. It is caused by a deficiency of N-ACETYLGALACTOSAMINE-4-SULFATASE (arylsulfatase B).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carbamazepine was given to the patient, which caused cessation of the spasms." | 1.48 | Hemifacial Spasm in Mucopolysaccharidosis Type VI (Maroteaux-Lamy Syndrome). ( Doja, A; Geraghty, M; Karir, A; Vassilyadi, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karir, A | 1 |
| Geraghty, M | 1 |
| Vassilyadi, M | 1 |
| Doja, A | 1 |
1 other study available for carbamazepine and Mucopolysaccharidosis VI
| Article | Year |
|---|---|
Hemifacial Spasm in Mucopolysaccharidosis Type VI (Maroteaux-Lamy Syndrome).
Topics: Anticonvulsants; Carbamazepine; Child, Preschool; Female; Head; Hemifacial Spasm; Humans; Mucopolysa | 2018 |